---
schema_version: "secwatch.filing_event.v1"
accession: "0001367644-24-000002"
form_type: "8-K"
ticker: "EBS"
cik: "0001367644"
company_name: "Emergent BioSolutions Inc."
filed_at: "2024-01-09T23:59:59+00:00"
generated_at: "2026-06-07T01:24:10.626119+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.05
calibrated_materiality_score: 0.05
confidence: "low"
source: SEC EDGAR
---

# Emergent BioSolutions announces presentation at J.P. Morgan conference; no material news disclosed

## Summary
- Company to present at 42nd Annual J.P. Morgan Healthcare Conference on Jan 11, 2024 at 9:00 a.m. PT.
- Presenters: Interim CEO Haywood Miller and CFO Rich Lindahl.
- Press release and slide deck furnished as exhibits; no financial results or guidance provided.
- Filing is procedural; no material operational or financial updates.

## SEC filing metadata
- accession: 0001367644-24-000002
- form_type: 8-K
- ticker: EBS
- cik: 0001367644
- company_name: Emergent BioSolutions Inc.
- filed_at: 2024-01-09T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.05
- calibrated_materiality_score: 0.05
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1367644/000136764424000002/0001367644-24-000002-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1367644/000136764424000002/ebs-20240109.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001367644-24-000002
- JSON: https://secwatch.observer/filing/0001367644-24-000002.json
- Plain text: https://secwatch.observer/filing/0001367644-24-000002.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.